158 related articles for article (PubMed ID: 15764048)
1. Thalidomide treatment for hypertrophic cutaneous lupus erythematosus.
Gambini D; Carrera C; Passoni E; Muratori S; Berti E; Caputo R
J Dermatolog Treat; 2004 Dec; 15(6):365-71. PubMed ID: 15764048
[TBL] [Abstract][Full Text] [Related]
2. [Thalidomide therapy for discoid lupus erythematosus].
Lyakhovisky A; Baum S; Shpiro D; Salomon M; Trau H
Harefuah; 2006 Jul; 145(7):489-92, 551. PubMed ID: 16900736
[TBL] [Abstract][Full Text] [Related]
3. [Thalidomide therapy of cutaneous lupus erythematosus].
Bohmeyer J; Achenbach A; Westenberger M; Stadler R
Hautarzt; 2002 Nov; 53(11):744-8. PubMed ID: 12402138
[TBL] [Abstract][Full Text] [Related]
4. Low-dose thalidomide is an effective second-line treatment in cutaneous lupus erythematosus.
Thomson KF; Goodfield MJ
J Dermatolog Treat; 2001 Sep; 12(3):145-7. PubMed ID: 12243705
[TBL] [Abstract][Full Text] [Related]
5. Thalidomide for the treatment of resistant cutaneous lupus: efficacy and safety of different therapeutic regimens.
Cuadrado MJ; Karim Y; Sanna G; Smith E; Khamashta MA; Hughes GR
Am J Med; 2005 Mar; 118(3):246-50. PubMed ID: 15745722
[TBL] [Abstract][Full Text] [Related]
6. Thalidomide in the treatment of cutaneous lupus refractory to conventional therapy.
Ordi-Ros J; Cortés F; Cucurull E; Mauri M; Buján S; Vilardell M
J Rheumatol; 2000 Jun; 27(6):1429-33. PubMed ID: 10852265
[TBL] [Abstract][Full Text] [Related]
7. Thalidomide in the treatment of refractory cutaneous lupus erythematosus: prognostic factors of clinical outcome.
Cortés-Hernández J; Torres-Salido M; Castro-Marrero J; Vilardell-Tarres M; Ordi-Ros J
Br J Dermatol; 2012 Mar; 166(3):616-23. PubMed ID: 21999437
[TBL] [Abstract][Full Text] [Related]
8. Positive and negative effects of thalidomide on refractory cutaneous lupus erythematosus.
Briani C; Zara G; Rondinone R; Iaccarino L; Ruggero S; Toffanin E; Ermani M; Ghirardello A; Zampieri S; Sarzi-Puttini P; Doria A
Autoimmunity; 2005 Nov; 38(7):549-55. PubMed ID: 16373260
[TBL] [Abstract][Full Text] [Related]
9. Chronic cutaneous lupus erythematosus. Thalidomide treatment of 11 patients.
Hasper MF
Arch Dermatol; 1983 Oct; 119(10):812-5. PubMed ID: 6614949
[TBL] [Abstract][Full Text] [Related]
10. A case series of 48 patients treated with thalidomide.
Doherty SD; Hsu S
J Drugs Dermatol; 2008 Aug; 7(8):769-73. PubMed ID: 18720694
[TBL] [Abstract][Full Text] [Related]
11. [Sarcoidosis: thalidomide treatment in ten patients].
Estines O; Revuz J; Wolkenstein P; Bressieux JM; Roujeau JC; Cosnes A
Ann Dermatol Venereol; 2001 May; 128(5):611-3. PubMed ID: 11427794
[TBL] [Abstract][Full Text] [Related]
12. Photoprotection by thalidomide in patients with chronic cutaneous and systemic lupus erythematosus: discordant effects on minimal erythema dose and sunburn cell formation.
Cummins DL; Gaspari AA
Br J Dermatol; 2004 Aug; 151(2):458-64. PubMed ID: 15327555
[TBL] [Abstract][Full Text] [Related]
13. [Thalidomide and thrombosis].
Flageul B; Wallach D; Cavelier-Balloy B; Bachelez H; Carsuzaa F; Dubertret L
Ann Dermatol Venereol; 2000 Feb; 127(2):171-4. PubMed ID: 10739975
[TBL] [Abstract][Full Text] [Related]
14. Low-dose thalidomide therapy for refractory cutaneous lesions of lupus erythematosus.
Housman TS; Jorizzo JL; McCarty MA; Grummer SE; Fleischer AB; Sutej PG
Arch Dermatol; 2003 Jan; 139(1):50-4. PubMed ID: 12533164
[TBL] [Abstract][Full Text] [Related]
15. [Use of oral isotretinoin in the treatment of cutaneous lupus erythematosus].
Vena GA; Coviello C; Angelini G
G Ital Dermatol Venereol; 1989 Jun; 124(6):311-5. PubMed ID: 2630441
[TBL] [Abstract][Full Text] [Related]
16. Refractory subacute cutaneous lupus erythematosus successfully treated with rituximab.
Kieu V; O'Brien T; Yap LM; Baker C; Foley P; Mason G; Prince HM; McCormack C
Australas J Dermatol; 2009 Aug; 50(3):202-6. PubMed ID: 19659984
[TBL] [Abstract][Full Text] [Related]
17. Treatment of the cutaneous lesions of systemic lupus erythematosus with thalidomide.
Atra E; Sato EI
Clin Exp Rheumatol; 1993; 11(5):487-93. PubMed ID: 8275583
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous lupus erythematosus: issues in diagnosis and treatment.
Walling HW; Sontheimer RD
Am J Clin Dermatol; 2009; 10(6):365-81. PubMed ID: 19824738
[TBL] [Abstract][Full Text] [Related]
19. Acute myocardial infarction in a patient with cutaneous lupus erythematosus treated with thalidomide.
Llambrich A; Romero D; Iranzo P; Segura S; Moreno JA; Herrero C
J Eur Acad Dermatol Venereol; 2007 Jan; 21(1):136-7. PubMed ID: 17207199
[No Abstract] [Full Text] [Related]
20. Low blood concentration of hydroxychloroquine in patients with refractory cutaneous lupus erythematosus: a French multicenter prospective study.
Francès C; Cosnes A; Duhaut P; Zahr N; Soutou B; Ingen-Housz-Oro S; Bessis D; Chevrant-Breton J; Cordel N; Lipsker D; Costedoat-Chalumeau N
Arch Dermatol; 2012 Apr; 148(4):479-84. PubMed ID: 22508872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
